Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Pre-surgery red and infrared light to reduce swelling after open rhinoplasty with osteotomies

Official title: Effects of Photobiomodulation With Red and Infrared Low-level Laser Diodes in Individuals Undergoing Rhinoplasty at a Single Centre: Protocol for a Randomized, Double-blind, Controlled Clinical Trial

Run by University of Nove de Julho · NCT07033039 · Data updated 2026-11-12

This will try a short preoperative session of red and infrared light in adults having primary open rhinoplasty with osteotomies to see if it reduces early periorbital swelling.

More Diabetic Macular Edema trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Nove de Julho
Academic / other
Locations1 site (São Paulo, São Paulo)
StatusRecruiting
StartedJanuary 30, 2026
Main results expectedNovember 30, 2029
Study endsNovember 30, 2030
Registry record updatedMarch 24, 2026
Trial IDNCT07033039 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults (18–60 years) with ASA I–II status scheduled for primary open rhinoplasty with piezo-assisted osteotomies and no significant comorbidities or contraindicated medications.

Probably not a fit

Patients undergoing closed or non‑piezo procedures, those on anticoagulants, anti‑inflammatories or corticosteroids, those with recent nasal fillers or isotretinoin use, or with significant comorbidities or intraoperative complications are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, randomized, double-blind, sham-controlled trial will enroll 60 adults undergoing primary open rhinoplasty with piezo-assisted osteotomies and randomize them 1:1 to active or sham photobiomodulation (660 nm and 808 nm) one hour before surgery. Intervention and sham procedures use identical application steps to maintain masking, and assessors are blinded; surgical and perioperative care are standardized across participants. The primary outcome is periorbital edema on postoperative day 3 measured with a validated ordinal clinical scale and standardized photographs, and secondary outcomes include ecchymosis, pain, analgesic use, nasal tip skin thickness, and patient-reported aesthetic and functional outcomes. Participants will be followed for up to 12 months to capture longer-term functional and cosmetic results.

Why it matters

Potential benefit: If effective, preoperative photobiomodulation could reduce early swelling and bruising after rhinoplasty, shortening recovery time and improving comfort and cosmetic outcomes.

How similar studies have gone: Small randomized and observational studies of low‑level laser or LED photobiomodulation in facial and postoperative settings have reported reductions in swelling and pain, but high‑quality sham‑controlled data specifically in rhinoplasty remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* individuals 18-60 years of age;
* ASA I or II; no comorbidities (no pre-existing diseases);
* indication for rhinoplasty;
* regardless of gender identity.

Exclusion criteria:

* use of anticoagulant,
* anti-inflammatory, or corticosteroid medications;
* indication for closed rhinoplasty;
* procedures not performed using the Piezo device (Schuster SW Surgery II);
* intraoperative complications (e.g., haemorrhage or technical difficulties);
* prior nasal filler with hyaluronic acid;
* use of vitamin A derivatives (oral isotretinoin or topical retinoic acid) within 30 days before surgery;
* or known allergy to any mandatory intra- or postoperative medication.

Where it's running

  • Hospital Paulista de Otorrinolaringologia
    São Paulo, São Paulo, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.